Are We Closer to Free Market Eugenics? The Crispr Controversy

Might the 2018 birth of two designer babies in China write the opening paragraph for the next chapter in the history of eugenics? The worldwide scientific community has tacitly put a moratorium on human clinical application of CRISPR gene editing, waiting until unknown risks can become known. But th...

Full description

Saved in:
Bibliographic Details
Published in:Zygon
Main Author: Peters, Ted 1941-
Format: Electronic Article
Language:English
Check availability: HBZ Gateway
Journals Online & Print:
Drawer...
Published: Wiley-Blackwell [2019]
In:Zygon
Year: 2019, Volume: 54, Issue: 1, Pages: 7-13
Standardized Subjects / Keyword chains:B CRISP/Cas method / Eugenics
Further subjects:B CRISPR
B Ethics
B Therapy
B Bioethics
B Enhancement
B gene editing
Online Access: Volltext (Resolving-System)
doi
Description
Summary:Might the 2018 birth of two designer babies in China write the opening paragraph for the next chapter in the history of eugenics? The worldwide scientific community has tacitly put a moratorium on human clinical application of CRISPR gene editing, waiting until unknown risks can become known. But this ethical agreement has been breached, and calls are now being heard for more rigorous regulations. Perhaps religious and spiritual leaders can join the bioethical chant: the yellow light of caution is flashing.
ISSN:1467-9744
Contains:Enthalten in: Zygon
Persistent identifiers:DOI: 10.1111/zygo.12501